Detalhe da pesquisa
1.
BET bromodomain inhibition as a therapeutic strategy to target c-Myc.
Cell
; 146(6): 904-17, 2011 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-21889194
2.
Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas.
Blood
; 142(22): 1871-1878, 2023 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37494698
3.
Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma.
Blood
; 139(26): 3708-3721, 2022 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35090171
4.
Genomic profiling for clinical decision making in lymphoid neoplasms.
Blood
; 140(21): 2193-2227, 2022 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36001803
5.
Expression of NrasQ61R and MYC transgene in germinal center B cells induces a highly malignant multiple myeloma in mice.
Blood
; 137(1): 61-74, 2021 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32640012
6.
Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling.
Nat Immunol
; 9(12): 1364-70, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18997792
7.
Identification of PIKfyve kinase as a target in multiple myeloma.
Haematologica
; 105(6): 1641-1649, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582538
8.
Che-1-induced inhibition of mTOR pathway enables stress-induced autophagy.
EMBO J
; 34(9): 1214-30, 2015 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25770584
9.
Multiple myeloma cells' capacity to decompose H2O2 determines lenalidomide sensitivity.
Blood
; 129(8): 991-1007, 2017 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28028022
10.
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma.
Blood
; 130(10): 1198-1204, 2017 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28684537
11.
Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes.
Blood
; 128(9): 1226-33, 2016 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27458004
12.
Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib.
Blood
; 128(20): 2415-2422, 2016 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27702799
13.
Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patients.
Ann Hematol
; 97(8): 1453-1462, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29623394
14.
MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites.
Nature
; 470(7332): 124-8, 2011 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21293379
15.
Initial genome sequencing and analysis of multiple myeloma.
Nature
; 471(7339): 467-72, 2011 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21430775
16.
Repair of DNA double-strand breaks by templated nucleotide sequence insertions derived from distant regions of the genome.
Proc Natl Acad Sci U S A
; 111(21): 7729-34, 2014 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-24821809
17.
Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells.
Blood
; 123(5): 725-33, 2014 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24345755
18.
TPL2 kinase regulates the inflammatory milieu of the myeloma niche.
Blood
; 123(21): 3305-15, 2014 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-24723682
19.
CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myeloma.
Blood
; 123(24): 3770-9, 2014 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24782505
20.
Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma.
Blood
; 124(4): 536-45, 2014 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24914135